Aquilo Capital Management logo

Aquilo Capital Management

North America, California, United States, San Francisco

Description

Aquilo Capital Management is an investment Firm.

Investor Profile

Aquilo Capital Management has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (50%)
  • Ireland (25%)
  • France (25%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Health Care
  • Life Science
  • Therapeutics
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aquilo Capital Management frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
Amati Global Investors
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Athyrium Capital Management LP
North America, New York, United States, New York
Co-Investments: 1
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 1
SC
North America, Oregon, United States, Bend
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Aquilo Capital Management?

Precision BioSciences

Durham, North Carolina, United States

Precision BioSciences is a biotechnology company dedicated to improving life.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquityMar 1, 2024
Amount Raised: $40,000,000
Sensorion

Clapiers, Languedoc-Roussillon, France

Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.

BiopharmaBiotechnologyHealth CareTherapeutics
Post Ipo EquityFeb 9, 2024
Amount Raised: $54,462,119
Amryt Pharma

Dublin, Dublin, Ireland

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

BiopharmaLife ScienceMedicalPharmaceutical
Post Ipo EquityDec 8, 2020
Amount Raised: $40,000,000
Pieris Pharmaceuticals

Boston, Massachusetts, United States

Pieris Pharmaceuticals is a clinical-stage biotechnology company applying its proprietary.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityNov 10, 2019
Amount Raised: $32,000,000